CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
In patients failing sequential or combination therapy with lamivudine and adefovir switching to adefovir plus entecavir is effective and leads to strong viral suppression in HBV mono-infected patients
DOI 10.1055/s-0029-1191943
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Lütgehetmann, J Schollmeyer, T Volz, C Sarrazin, AW Lohse, S Polywka, M Dandri, J Petersen
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: In patients failing lamivudine or adefovir monotherapy due to suboptimal viral response or development of viral resistance switching or add-on therapy has been the common therapeutical approach used in clinical practice over the last years. Although both approaches often lead to suppression of viral replication, a subset of mainly HBeAg positive patients with highly replicative active HBV remains viremic. Thes…
Zitieren
Zitierempfehlung
M Lütgehetmann, J Schollmeyer, T Volz, C Sarrazin, AW Lohse, S Polywka, M Dandri, J Petersen (2009) In patients failing sequential or combination therapy with lamivudine and adefovir switching to adefovir plus entecavir is effective and leads to strong viral suppression in HBV mono-infected patients. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0029-1191943
Mit CareLit weiterarbeiten